SWM
TXG icon

Spire Wealth Management’s 10x Genomics TXG Stock Holding History

Spire Wealth Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,000
Closed -$14.4K – 2576
2024
Q4 		$14.4K Buy
+1,000
New +$15.8K ﹤0.01% 1734
2024
Q1 		– Sell
-19
Closed -$794 – 2398
2023
Q4 		$794 Hold
19
– – ﹤0.01% 2299
2023
Q3 		$784 Hold
19
– – ﹤0.01% 2292
2023
Q2 		$1.06K Buy
+19
New +$1.03K ﹤0.01% 2301
2022
Q1 		– Sell
-732
Closed -$109K – 2868
2021
Q4 		$109K Buy
+732
New +$112K ﹤0.01% 1370
2021
Q2 		– Sell
-445
Closed -$74K – 2962
2021
Q1 		$74K Buy
+445
New +$76.8K ﹤0.01% 1533

Other funds holding TXG

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Spire Wealth Management's TXG Position: Q1 2025 in Review

Spire Wealth Management sold out of 10x Genomics (TXG) in Q1 2025, closing a stake of 1,000 shares — an estimated $14.4K sold.

Spire Wealth Management first reported a position in TXG in Q1 2021 and held it in 6 quarters. The position peaked at $109K in Q4 2021. 274 funds tracked by Wall St. Rank hold TXG as of Q1 2025.

  • Spire Wealth Management reported no remaining 10x Genomics position as of Q1 2025 after selling out during the quarter.
  • Spire Wealth Management sold 1,000 10x Genomics shares in Q1 2025, an estimated $14.4K.
  • Spire Wealth Management first reported a position in 10x Genomics in Q1 2021 and held it in 6 quarters.
  • Spire Wealth Management's 10x Genomics position peaked at $109K in Q4 2021.
  • 274 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2025.

Based on Spire Wealth Management's 13F filing for Q1 2025, filed 23 Apr 2025.